| LYEL |
Lyell Immunopharma, Inc. |
15 May 2025 |
1 |
$0 |
4 |
Director |
19 May 2025, 18:43 |
| MRNA |
Moderna, Inc. |
30 Apr 2025 |
3 |
$0 |
4 |
Director |
01 May 2025, 16:30 |
| MDT |
Medtronic plc |
28 Apr 2025 |
2 |
+$156,782 |
4 |
Director |
30 Apr 2025, 16:20 |
| /report/000141588925010340-nabel-elizabeth-g-2025-04-08 |
Accolade, Inc. |
08 Apr 2025 |
3 |
-$295,133 |
4 |
Director |
08 Apr 2025, 10:21 |
| /report/000112760225008236-nabel-elizabeth-g-2025-03-03 |
Accolade, Inc. |
03 Mar 2025 |
1 |
$0 |
4 |
Director |
05 Mar 2025, 12:57 |
| /report/000112760225007668-nabel-elizabeth-g-2025-02-28 |
Accolade, Inc. |
28 Feb 2025 |
2 |
$0 |
4 |
Director |
04 Mar 2025, 11:08 |
| /report/000112760224028585-nabel-elizabeth-g-2024-12-02 |
Accolade, Inc. |
02 Dec 2024 |
2 |
$0 |
4 |
Director |
04 Dec 2024, 11:00 |
| /report/000112760224023514-nabel-elizabeth-g-2024-09-03 |
Accolade, Inc. |
03 Sep 2024 |
2 |
$0 |
4 |
Director |
05 Sep 2024, 09:39 |
| /report/000112760224021873-nabel-elizabeth-g-2024-08-06 |
Accolade, Inc. |
06 Aug 2024 |
2 |
$0 |
4 |
Director |
08 Aug 2024, 14:20 |
| /report/000112760224021857-nabel-elizabeth-g-2024-08-06 |
Accolade, Inc. |
06 Aug 2024 |
1 |
$0 |
4 |
Director |
08 Aug 2024, 14:01 |
| LYEL |
Lyell Immunopharma, Inc. |
14 Jun 2024 |
1 |
$0 |
4 |
Director |
17 Jun 2024, 16:09 |
| /report/000112760224017163-nabel-elizabeth-g-2024-05-31 |
Accolade, Inc. |
31 May 2024 |
2 |
$0 |
4 |
Director |
03 Jun 2024, 09:00 |
| MRNA |
Moderna, Inc. |
03 May 2024 |
4 |
$0 |
4 |
Director |
07 May 2024, 16:48 |
| MDT |
Medtronic plc |
01 May 2024 |
1 |
-$15,531 |
4 |
Director |
03 May 2024, 13:10 |
| MDT |
Medtronic plc |
29 Apr 2024 |
1 |
+$175,062 |
4 |
Director |
01 May 2024, 17:15 |
| /report/000112760224008327-nabel-elizabeth-g-2024-03-01 |
Accolade, Inc. |
01 Mar 2024 |
1 |
$0 |
4 |
Director |
05 Mar 2024, 09:32 |
| /report/000112760224007979-nabel-elizabeth-g-2024-02-29 |
Accolade, Inc. |
29 Feb 2024 |
2 |
$0 |
4 |
Director |
04 Mar 2024, 09:06 |
| /report/000112760223028679-nabel-elizabeth-g-2023-11-30 |
Accolade, Inc. |
30 Nov 2023 |
2 |
$0 |
4 |
Director |
04 Dec 2023, 13:55 |
| LYEL |
Lyell Immunopharma, Inc. |
08 Sep 2023 |
1 |
$0 |
4 |
Director |
08 Sep 2023, 16:23 |
| /report/000112760223023465-nabel-elizabeth-g-2023-08-31 |
Accolade, Inc. |
31 Aug 2023 |
2 |
$0 |
4 |
Director |
31 Aug 2023, 15:11 |
| /report/000112760223023055-nabel-elizabeth-g-2023-08-18 |
Accolade, Inc. |
18 Aug 2023 |
1 |
$0 |
4 |
Director |
22 Aug 2023, 15:27 |
| /report/000112760223021387-nabel-elizabeth-g-2023-07-25 |
Accolade, Inc. |
25 Jul 2023 |
2 |
$0 |
4 |
Director |
27 Jul 2023, 14:49 |
| LYEL |
Lyell Immunopharma, Inc. |
16 Jun 2023 |
1 |
$0 |
4 |
Director |
20 Jun 2023, 16:47 |
| /report/000112760223017338-nabel-elizabeth-g-2023-05-31 |
Accolade, Inc. |
31 May 2023 |
2 |
$0 |
4 |
Director |
01 Jun 2023, 16:00 |
| MRNA |
Moderna, Inc. |
03 May 2023 |
2 |
$0 |
4 |
Director |
05 May 2023, 16:13 |
| MDT |
Medtronic plc |
01 May 2023 |
2 |
+$159,764 |
4 |
Director |
03 May 2023, 16:31 |
| MRNA |
Moderna, Inc. |
28 Apr 2023 |
2 |
$0 |
4 |
Director |
01 May 2023, 17:43 |
| /report/000112760223008187-nabel-elizabeth-g-2023-03-01 |
Accolade, Inc. |
01 Mar 2023 |
1 |
$0 |
4 |
Director |
02 Mar 2023, 12:05 |
| /report/000112760222019813-nabel-elizabeth-g-2022-07-26 |
Accolade, Inc. |
26 Jul 2022 |
1 |
$0 |
4 |
Director |
27 Jul 2022, 13:17 |
| /report/000112760222019721-nabel-elizabeth-g-2022-07-21 |
Accolade, Inc. |
21 Jul 2022 |
2 |
$0 |
4 |
Director |
25 Jul 2022, 14:24 |
| LYEL |
Lyell Immunopharma, Inc. |
08 Jun 2022 |
1 |
$0 |
4 |
Director |
10 Jun 2022, 16:14 |
| MDT |
Medtronic plc |
02 May 2022 |
2 |
-$27,015 |
4 |
Director |
04 May 2022, 18:23 |
| MRNA |
Moderna, Inc. |
28 Apr 2022 |
4 |
$0 |
4 |
Director |
02 May 2022, 16:37 |
| /report/000112760221022483-nabel-elizabeth-g-2021-07-22 |
Accolade, Inc. |
22 Jul 2021 |
3 |
$0 |
4 |
Director |
26 Jul 2021, 13:42 |
| LYEL |
Lyell Immunopharma, Inc. |
16 Jun 2021 |
0 |
$0 |
3 |
Director |
16 Jun 2021, 19:19 |
| /report/000112760221019031-nabel-elizabeth-g-2021-06-02 |
Accolade, Inc. |
02 Jun 2021 |
1 |
$0 |
4 |
Director |
03 Jun 2021, 17:24 |
| /report/000112760221019028-nabel-elizabeth-g-2021-06-02 |
Accolade, Inc. |
02 Jun 2021 |
0 |
$0 |
3 |
Director |
03 Jun 2021, 17:22 |